About
Professor Dan Adarka has been practicing oncology for over 22 years, accumulating a total clinical experience exceeding 37 years. He is renowned in Israel as one of the most skilled oncologists. Throughout his career, Professor Adarka has been persistent in his pursuit to combat cancer with a modern and comprehensive approach, having saved thousands of patients and significantly improving the condition of many others. His specialties include the treatment of stomach cancer, colorectal cancer, pancreatic cancer, esophageal cancer, liver and bile duct cancers, neuroendocrine tumors, gastrointestinal stromal tumors (GIST), and tumors with difficult-to-define localization. In his practice, Professor Adarka utilizes the latest advancements in clinical oncology and radiotherapy. This includes state-of-the-art chemotherapy and biological agents, targeted and monoclonal chemotherapy, and radiation therapy using TrueBeam systems of the latest generation, known for their exceptional precision and safety in radiation delivery. Professor Adarka is the author of 10 patents for anti-cancer drugs and has published over 135 scientific papers, making a significant contribution to the development of global oncology. Additionally, Professor Adarka teaches at Tel Aviv University and actively participates in numerous scientific research projects both in Israel and abroad.